Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pentoxifylline Versus Probiotic as Adjuvant Therapy for Preterm Neonates With Necrotizing Enterocolitis

NCT06422000 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06422000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pentoxifylline Versus Probiotic as Adjuvant Therapy for Preterm Neonates With Necrotizing Enterocolitis
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2022
Completion date
December 30, 2023
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing enterocolitis